AlphAIAlphAI — Financial news for AI agents
sci-tech-today.comSEP 112 min read$INNV

InnovAge Holding Corp. Q4 Fiscal 2026 Earnings: Revenue Beats $261.95 Million

InnovAge Holding Corp. (INNV) reported Q4 2026 revenue of $261.95M, beating estimates, but EPS of $0.06 missed expectations. Full-year revenue rose 15.9% to $989.71M, while net loss narrowed to $0.68M. Shares rose 9.03% after-hours. FY2027 guidance projects revenue of $1.05B-$1.085B and Adjusted EBITDA of $105M-$115M.

Original reporting
sci-tech-today.com
Published Sep 11, 2026, 1:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 11, 2026, 2:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
InnovAge Holding Corp. Q4 Fiscal 2026 Earnings: Revenue Beats $261.95 Million — source image
Source · sci-tech-today.com
Decision brief

The 30-second read

$INNVBullishMed
01

Why it matters

The earnings beat and guidance raise expectations for continued top‑line growth, while the EPS miss and litigation expenses temper the outlook.

02

Market read

Earnings release provides fresh data for traders; after‑hours price jump indicates immediate market impact.

03

What to watch

Litigation and settlement expenses remain sizable; cash burn and debt levels need monitoring.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

InnovAge Holding Corp. (NASDAQ: INNV) provides PACE services for dual‑eligible seniors. The company reported Q4 FY2026 results with revenue $261.95 M, EPS $0.06, and raised FY2027 guidance.

Company-level read

Ticker impact

$INNVBullishHigh confidence
Context

Q4 FY2026 earnings beat revenue expectations but missed EPS consensus, with after‑hours price jump of ~9% and FY2027 guidance raised to $1.05‑$1.085 B.

Expected impact

Potential short‑term rally on after‑hours momentum; watch for pull‑back if EPS concerns dominate.

Evidence & confidence

Strong top‑line growth and guidance lift outweigh modest EPS miss; market already reacted positively.

Market effects

Sector

Highlights growth potential in the PACE healthcare services niche, may boost peers with similar capitation models.

Regional

Positive for Colorado and other states where INNV operates, could influence regional healthcare stocks.

Global

Limited to U.S. healthcare services sector; no broader macro impact.

Counterpoint

What could challenge this read

EPS miss and ongoing litigation costs could signal underlying profitability challenges, suggesting caution.

Key entities

  • Executive
    Patrick Blair

    CEO of InnovAge, provided commentary on FY2026 performance and future strategy.

  • Executive
    Ben Adams

    CFO of InnovAge, discussed cash position and FY2027 guidance.

Read at source← All news

Related articles

SEP 10
$INNVMedAI 8/10

InnovAge Holding Corp. Q4 2026 Earnings Call Summary

InnovAge Holding Corp. completed 'InnovAge 2.0' in 2026, focusing on operational improvements. 'InnovAge 3.0' will prioritize scaling and expansion. For 2027, the company projects 1.5% to 2.0% net Medicare rate increases and revenue of $1.05B to $1.085B, with growth driven by enrollment and utilization management. Management prefers M&A over de novo centers for capital allocation.

yahoo.com3 min
SEP 9
$INNVHighAI 8/10

InnovAge (INNV) Q4 2026 Earnings Call Transcript

InnovAge (INNV) reported Q4 2026 revenue of $262.0M, up 18.3% YoY, and net income of $9.8M. Full-year revenue rose 15.9% to $989.7M, with adjusted EBITDA increasing 174.2% to $94.6M. The company guided FY 2027 revenue to $1.05B-$1.085B and adjusted EBITDA to $105M-$115M, citing census growth and rate increases. Management highlighted expansion plans and potential M&A activity, while noting risks from Medicaid rate uncertainties in key states.

fool.com3 min
SEP 9
$INNVHighAI 9/10

InnovAge shares jump 13% as fiscal 2027 guidance tops $1bn

InnovAge Holding Corp (INNV) reported fiscal 2026 results and fiscal 2027 guidance of $1.05bn to $1.085bn in revenue. Shares rose 13.12% to $11.90. Management reported a 175% increase in adjusted EBITDA, though GAAP net income showed volatility. The company plans to scale operations and expand value-based care. Three private-equity sponsors filed SEC forms around the earnings release.

financial-news.co.uk2 min
SEP 9
$INNVHighAI 8/10

Why is InnovAge stock up 14% today?

InnovAge (INNV) stock rose 14.6% in pre-market trading after reporting fiscal Q4 and full-year 2026 results. Adjusted EBITDA increased 175% to $94.6M, revenue grew 15.9% to $989.7M, and net loss narrowed to $0.7M. The company issued fiscal 2027 guidance targeting revenue of $1.05B-$1.085B and adjusted EBITDA of $105M-$115M. CEO Patrick Blair highlighted a strategic focus on scaling through technology, AI, and potential acquisitions.

investing.com2 min
SEP 8
$INNVMedAI 9/10

InnovAge Q4 Earnings Call Highlights

InnovAge reported Q4 cost of care rose 16.1% to $312.1M. It held $97.9M in cash, $43.4M in short-term investments, and $63.3M in debt. The company projected fiscal 2027 revenue of $1.05B-$1.085B, adjusted EBITDA of $105M-$115M, and 5%-7.5% growth. It outlined 'InnovAge 3.0' strategy, focusing on scaling and acquisitions.

yahoo.com2 min